Stock TRDA ENTRADA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Entrada Therapeutics, Inc.

Equities

TRDA

US29384C1080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-13 pm EDT 		5-day change 1st Jan Change
16.45 USD +3.59% Intraday chart for Entrada Therapeutics, Inc. +4.11% +9.01%
Jun. 10 Transcript : Entrada Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 04:00 PM
May. 20 Entrada Therapeutics Insider Sold Shares Worth $287,695, According to a Recent SEC Filing MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ENTRADA THERAPEUTICS, INC. Stock Entrada Therapeutics, Inc.
 522M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 111B
BIONTECH SE Stock BioNTech SE
 23.17B -
ARGENX SE Stock argenx SE
 22.94B -
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 17.42B
  1. Stock Market
  2. Equities
  3. TRDA Stock
  4. Charts Entrada Therapeutics, Inc.
  5. Sector Chart